This interview was first published on Pharma Boardroom on 18 September 2018. In this first installment of an exclusive two-part interview, IFPMA’s Thomas Cueni expounds on how IFPMA has grown from an association of associations to also include companies as members, key milestones in the organization’s 50 years of existence, and what he sees as...
Read moreOver a hundred Pharma industry management and healthcare professionals, medical and scientific advisors receive training on how to implement compliance programs. The African Stakeholder Forum will discuss progress across Africa in raising the standards in the ethics and business integrity space. Part of the Forum is a session to raise awareness about the impact of...
Read moreThis blog was first published on the Diplomatic Courier on 13 September 2018 The alarm has rightly been sounded on a silent killer. Faced with the staggering figure that 40 million people lose their lives each year to non-communicable diseases (NCDs), it is time to leave our comfort zones and consider how to best...
Read moreAt IFPMA, across our member companies and throughout our national member associations, we need to champion integrity, ethics, and compliance. Implementing the new and revised Code in full is about walking the talk, about earning our license to operate. As with all things, it is work in progress and I am sure more needs to be done. But we will never stop trying to improve.
Read more
The IFPMA Ethos instils a culture of ethics and integrity that guides the way we behave and interact with the rest of the global health community. It is centered on trust, care, fairness, respect, and honesty.
Read more
The IFPMA Code of Practice is a living document and has been revised five times over recent decades, ensuring that practices in the biopharmaceutical industry are governed by ethical standards in line with societal expectations. The new IFPMA Code of Practice will come into effect on 1st January 2019. This Q&A summarizes the key changes...
Read moreDelivered by Cyntia Genolet, Senior Manager Global Health Policy, IFPMA Thank you for the opportunity to contribute to this important discussion today. IFPMA represents leading research-based pharmaceutical companies as well as national and regional industry associations across the world, including three in Africa. IFPMA notes the report on the Status of implementation of the...
Read more